GlassScriptPhysician profile
Lori A Sumner
NPI 1649283458
$3,882.87
in general payments reported to CMS, 2019-2025
23 companies · $620 in 2025
The $620 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,048 · 2022: $1,009 · 2023: $925 · 2024: $282 · 2025: $620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,806 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,806.49 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,315.43 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $420.50 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Astrazeneca Pharmaceuticals LP | $411.76 | 2021-2024 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $367.91 | 2022-2024 | |
| Amgen INC. | $233.36 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $165.61 | 2021-2023 | Trintellix |
| Inspire Medical Systems, INC. | $110.58 | 2023 | Inspire |
| Pfizer INC. | $94.64 | 2021-2023 | |
| Abbvie INC. | $93.87 | 2021-2023 | |
| Intuitive Surgical, INC. | $81.78 | 2023 | |
| Amarin Pharma, INC. | $78.90 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $63.69 | 2021 | |
| Exact Sciences Corporation | $58.97 | 2023-2024 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.12 | 2021-2022 | |
| Glaxosmithkline, LLC. | $52.20 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $51.50 | 2023-2025 | Dexcom G6 Transmitter |
| Kowa Pharmaceuticals America, INC. | $46.78 | 2021 | |
| Eisai INC. | $45.42 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $32.19 | 2021 | |
| Currax Pharmaceuticals LLC | $28.13 | 2021-2023 | Contrave |
| Biohaven Pharmaceutical Holding Company LTD. | $28.08 | 2022 | |
| Hologic Sales and Service, LLC | $26.88 | 2021 | |
| Dynavax Technologies Corporation | $18.57 | 2023 | Heplisav-B |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Sumner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.